[{"data":1,"prerenderedAt":170},["ShallowReactive",2],{"drug-dipyridamole":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":21,"regimens":52,"contraindications":77,"warnings":87,"renal":88,"monitoring":89,"interactions":90,"review":91,"examples":94,"atc":100,"iran":102,"usApproval":122,"links":128,"populations":144},"dipyridamole",1,{"fa":7,"en":8},"دی‌پیریدامول","Dipyridamole","blood",{"fa":11,"en":12},"مهارکننده پلاکت","Platelet inhibitor",[14],{"name":15,"market":16},"Persantine","US",[18,19,20],"persantine","پرسانتین","دیپیریدامول",[22,36,44],{"id":23,"form":24,"route":25,"label":26,"concentration":27,"markets":31,"refs":32},"tab-25","tablet","oral","25 mg tablet",{"amount":28,"unit":29,"perUnit":24,"scored":30},25,"mg",false,[16],[33],{"source":34,"section":35},"fda-dipyridamole","How Supplied",{"id":37,"form":24,"route":25,"label":38,"concentration":39,"markets":41,"refs":42},"tab-50","50 mg tablet",{"amount":40,"unit":29,"perUnit":24,"scored":30},50,[16],[43],{"source":34,"section":35},{"id":45,"form":24,"route":25,"label":46,"concentration":47,"markets":49,"refs":50},"tab-75","75 mg tablet",{"amount":48,"unit":29,"perUnit":24,"scored":30},75,[16],[51],{"source":34,"section":35},[53],{"id":54,"disease":55,"label":56,"population":59,"type":63,"unit":29,"dose":64,"refs":67,"notes":70},"valve","valve-thromboprophylaxis",{"fa":57,"en":58},"پیشگیری از ترومبوآمبولی پس از تعویض دریچه (همراه وارفارین) — ۷۵ تا ۱۰۰ mg چهار بار در روز","After heart-valve replacement (with warfarin) — 75–100 mg four times daily",{"minAge":60},{"value":61,"unit":62},18,"year","fixed",{"perDose":48,"perDoseMax":65,"dosesPerDay":66},100,4,[68],{"source":34,"section":69},"Dosage and Administration",[71],{"text":72,"refs":75},{"fa":73,"en":74},"همراه وارفارین؛ آسپرین همزمان با کومارین داده نشود.","With warfarin; do not give aspirin with coumarin anticoagulants.",[76],{"source":34,"section":69},[78],{"id":79,"severity":80,"text":81,"refs":84},"hyper","block",{"fa":82,"en":83},"حساسیت به دی‌پیریدامول.","Hypersensitivity to dipyridamole.",[85],{"source":34,"section":86},"Contraindications",[],[],[],[],{"status":92,"reviewer":93,"date":93},"unverified",null,[95],{"regimen":54,"formulation":45,"input":96,"expect":99},{"ageYears":97,"weightKg":98},60,70,{"perDose":48,"tabletsPerDoseRounded":5},[101],"B01AC07",{"status":103,"forms":104,"refs":117},"registered",[105,109,113],{"code":106,"en":107,"fa":108},"00459","DIPYRIDAMOLE 10MG\u002F2ML AMP","آمپول دی‌پیریدامول ۱۰ میلی‌گرم \u002F ۲ میلی‌لیتر",{"code":110,"en":111,"fa":112},"00460","DIPYRIDAMOLE 25MG TAB","قرص دی‌پیریدامول ۲۵ میلی‌گرم",{"code":114,"en":115,"fa":116},"00461","DIPYRIDAMOLE 75MG TAB","قرص دی‌پیریدامول ۷۵ میلی‌گرم",[118],{"source":119,"section":120,"url":121},"darooyab-generic","G-1644\u002FDipyridamole","https:\u002F\u002Fwww.darooyab.ir\u002FG-1644\u002FDipyridamole",{"kind":123,"refs":124,"id":127},"ANDA",[125],{"source":34,"section":126},"SPL approval \u002F marketing category","ANDA040782",[129,132,136,139,142],{"kind":130,"url":131,"label":127},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=040782",{"kind":133,"url":134,"label":135},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=a18b2af5-7c4a-4b7f-92c7-8a76e34da373","FDA Dipyridamole",{"kind":137,"url":138,"label":8},"medlineplus","https:\u002F\u002Fmedlineplus.gov\u002Fdruginfo\u002Fmeds\u002Fa682830.html",{"kind":140,"url":141,"label":101},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=B01AC07",{"kind":143,"url":121,"label":8},"darooyab",{"pregnancy":145,"lactation":154,"pediatric":162},{"level":146,"text":147,"quote":150,"refs":151},"caution",{"fa":148,"en":149},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Because animal reproduction studies are not always predictive of human response, dipyridamole tablets should be used during pregnancy only if clearly needed.",[152],{"source":34,"section":153},"Pregnancy",{"level":146,"text":155,"quote":158,"refs":159},{"fa":156,"en":157},"برچسب: در شیردهی با احتیاط؛ متن برچسب را ببینید.","Label: use with caution while breastfeeding; see the label text.","As dipyridamole is excreted in human milk, caution should be exercised when dipyridamole tablets are administered to a nursing woman.",[160],{"source":34,"section":161},"Nursing Mothers",{"level":146,"text":163,"quote":166,"refs":167},{"fa":164,"en":165},"برچسب برای کودکان شرط، محدودیت سنی یا نکته دارد؛ جمله برچسب در زیر آمده است.","The label has conditions, age limits or notes for children; the label sentence is quoted below.","Safety and effectiveness in the pediatric population below the age of 12 years have not been established.",[168],{"source":34,"section":169},"Pediatric Use",1792191538786]